Jinling Pharmaceutical (000919.SZ) reduced investment in securities and strove to develop medical service industry

Search by Type

Report Charts News

Search by Company

Code Company name

Jinling Pharmaceutical (000919.SZ) reduced investment in securities and strove to develop medical service industry

Date:2011-11-25xujintao

During Jan. to Sept. 2011, performance of Jiling Pharmaceutical steadily improved. Its operating revenue reached RMB1.67 billion, up 3.9% YoY; while its net income achieved RMB160 million, a rise o...

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

Related Reports

China Animal Vaccine Industry Report, 2010-20112011-08-18
China Human Vaccine Industry Report, 2010-20112011-05-27
China Pharmaceutical Chain Industry Report, 20102010-12-14
China Chemical Pharmaceutical Industry Report, 2009-20102010-12-08
China Vaccine Industry Report, 2009-20102010-09-26
China Animal Vaccine Industry Report, 2009-20102010-06-25
China Pharmaceutical Industry Statistics, 2000-20092010-02-09
China Antibiotic Market Report, 2008-20092009-12-25